Addition of intratympanic steroid or hyperbaric oxygen treatment to systemic steroid treatment in sudden idiopathic sensorineural hearing loss treatment, and long-term results of salvage treatment.

What Researchers Did

This retrospective study investigated the effectiveness of adding intratympanic steroid or hyperbaric oxygen therapy to systemic steroid treatment for idiopathic sudden sensorineural hearing loss.

What They Found

Among 96 patients, there was no statistically significant difference in recovery or success rates between groups receiving systemic steroids alone, systemic steroids plus intratympanic steroids, or systemic steroids plus hyperbaric oxygen after initial treatment (P=0.66 and P=0.248, respectively). Salvage treatment yielded successful results in only 3 patients (5%).

What This Means for Canadian Patients

Canadian patients experiencing sudden idiopathic sensorineural hearing loss may not see additional benefit from adding intratympanic steroids or hyperbaric oxygen to standard systemic steroid treatment. This suggests that current initial treatment approaches might be sufficient without these adjunct therapies.

Canadian Relevance

This study has no direct Canadian connection.

Study Limitations

As a retrospective study, it may be limited by its design and the relatively small sample size.